Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.

Kroes JA, Alfonso-Cristancho R, Bansal AT, Berret E, Bieksiene K, Bourdin A, Brussino L, Canhoto D, Cardini C, Celik G, Csoma Z, Dahlén B, Damadoglu E, Eger K, Gauquelin L, Gemicioglu B, Goksel O, Graff S, Heffler E, Hofstee HB, Howarth P, Jakes RW, Jaun F, Kalinauskaite-Zukauske V, Kopač P, Kwon N, Loureiro CC, Lozoya García V, Masoli M, Rezelj MP, Pérez De Llano L, Popović-Grle S, Ramos-Barbón D, Sà Sousa A, Samitas K, Schleich F, Sirena C, Skrgat S, Zervas E, Zichnalis G, Bel EH, Sont JK, Hashimoto S, Ten Brinke A

Open source

DOI
10.1183/23120541.00745-2022
Published
2023 Mar
Container
ERJ open research
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00745-2022,
  title = {Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.},
  author = {Kroes JA and Alfonso-Cristancho R and Bansal AT and Berret E and Bieksiene K and Bourdin A and Brussino L and Canhoto D and Cardini C and Celik G and Csoma Z and Dahlén B and Damadoglu E and Eger K and Gauquelin L and Gemicioglu B and Goksel O and Graff S and Heffler E and Hofstee HB and Howarth P and Jakes RW and Jaun F and Kalinauskaite-Zukauske V and Kopač P and Kwon N and Loureiro CC and Lozoya García V and Masoli M and Rezelj MP and Pérez De Llano L and Popović-Grle S and Ramos-Barbón D and Sà Sousa A and Samitas K and Schleich F and Sirena C and Skrgat S and Zervas E and Zichnalis G and Bel EH and Sont JK and Hashimoto S and Ten Brinke A},
  year = {2023},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00745-2022},
  url = {https://doi.org/10.1183/23120541.00745-2022}
}

RIS

TY  - JOUR
TI  - Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
AU  - Kroes JA
AU  - Alfonso-Cristancho R
AU  - Bansal AT
AU  - Berret E
AU  - Bieksiene K
AU  - Bourdin A
AU  - Brussino L
AU  - Canhoto D
AU  - Cardini C
AU  - Celik G
AU  - Csoma Z
AU  - Dahlén B
AU  - Damadoglu E
AU  - Eger K
AU  - Gauquelin L
AU  - Gemicioglu B
AU  - Goksel O
AU  - Graff S
AU  - Heffler E
AU  - Hofstee HB
AU  - Howarth P
AU  - Jakes RW
AU  - Jaun F
AU  - Kalinauskaite-Zukauske V
AU  - Kopač P
AU  - Kwon N
AU  - Loureiro CC
AU  - Lozoya García V
AU  - Masoli M
AU  - Rezelj MP
AU  - Pérez De Llano L
AU  - Popović-Grle S
AU  - Ramos-Barbón D
AU  - Sà Sousa A
AU  - Samitas K
AU  - Schleich F
AU  - Sirena C
AU  - Skrgat S
AU  - Zervas E
AU  - Zichnalis G
AU  - Bel EH
AU  - Sont JK
AU  - Hashimoto S
AU  - Ten Brinke A
PY  - 2023
JO  - ERJ open research
DO  - 10.1183/23120541.00745-2022
UR  - https://doi.org/10.1183/23120541.00745-2022
ER  -

APA

JA, K., R, A., AT, B., E, B., K, B., A, B., L, B., D, C., C, C., G, C., Z, C., B, D., E, D., K, E., L, G., B, G., O, G., S, G., E, H., HB, H., P, H., RW, J., F, J., V, K., P, K., N, K., CC, L., V, L. G., M, M., MP, R., L, P. D. L., S, P., D, R., A, S. S., K, S., F, S., C, S., S, S., E, Z., G, Z., EH, B., JK, S., S, H., & A, T. B. (2023). Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.. ERJ open research. https://doi.org/10.1183/23120541.00745-2022

Source records